SCALP MICRO USA, LLC – Trademark Portfolio

Entity Type: 16

SCALP MICRO USA, LLC holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 3 filings in this category. The portfolio also extends into Class 2 (Paints) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include FOLICULE and SCALP MICRO USA. The owner is based in Bethpage, NY.

92 South Windhorst Avenue

Bethpage, NY 11714

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

SCALP MICRO USA, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

44
Medical Services (3 filings)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

2
Paints (1 filing)

Paints, varnishes, lacquers; preservatives against rust and against deterioration of wood

Frequently Asked Questions

How many trademarks does SCALP MICRO USA, LLC have?

SCALP MICRO USA, LLC has 4 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned, 1 cancelled.

What trademark classes does SCALP MICRO USA, LLC file in?

SCALP MICRO USA, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 2 (Paints). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.

What are SCALP MICRO USA, LLC's most well-known trademarks?

SCALP MICRO USA, LLC's registered trademark portfolio includes well-known marks such as FOLICULE and SCALP MICRO USA. These are among 2 currently registered trademarks in the portfolio.

What is SCALP MICRO USA, LLC's trademark registration success rate?

SCALP MICRO USA, LLC has a 50% trademark registration rate, with 2 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.